phenylephrine-hydrochloride and Telangiectasis

Topics: Acne Vulgaris; Adult; Carcinoma, Basal Cell; Dermatitis; Diagnosis, Differential; Erythema; Exanthema; Eye Manifestations; Female; Humans; Lupus Vulgaris; Male; Middle Aged; Nose; Rosacea; Sarcoidosis; Skin Neoplasms; Telangiectasis

To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device.. Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects' current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed.. Of the subjects with available follow-up data, 44% maintained "complete vessel clearance," 44% dropped down one grade to "almost complete vessel clearance," and 11% dropped down to "moderately clear vessel clearance." All showed clinically significant improvement in nasal telangiectasias from baseline.. The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1-year follow-up. Lasers Surg. Med. 50:61-63, 2018. © 2017 Wiley Periodicals, Inc.

Topics: Follow-Up Studies; Humans; Lasers, Dye; Nose; Telangiectasis; Time Factors; Treatment Outcome

Destruction of blood vessels by selective photothermolysis has been successfully achieved using a number of different laser and light systems, none of which provide significant independent variation in parameters such as wavelength.. To evaluate the safety and efficacy of a novel configurable device in the treatment of nasal telangiectasias.. Fifteen subjects aged 42-73 with Fitzpatrick skin types I and II were treated for nasal telangiectasias of various sizes. Efficacy was measured by blinded analysis of pre and post images and self-assessment by the subjects. The primary endpoint was a 2-point improvement of telangiectasia based on a 5-point Telangiectasia Scale comparing the pre-treatment photograph to the post-treatment photograph at 30 days post final treatment by an independent reviewer. Treatment completion was defined as >75% vessel clearance. The TRASER (Total Reflection Amplification of Spontaneous Emission Radiation) was configured to produce a narrow spectral output, peaking at 541 ± 5 nm, with 20-40 millisecond pulses over an energy density range of 15-40 J/cm. All 13 subjects (100%) in the efficacy population achieved procedure success at the end of the final treatment, that is a 2-point improvement of telangiectasis on the telangiectasia scale (pre- vs. post-treatment). A single treatment was effective in >75% of patients with at least a 75% reduction in blood vessels. Larger vessels responded well to longer pulse durations (40 milliseconds) while smaller vessels responded best to shorter pulse durations (25 milliseconds). No serious adverse events (SAEs) were recorded.. Short-term (1 month) follow up.. The TRASER device is a safe and effective option for treatment of nasal telangiectasias with all subjects meeting primary endpoint success at the end of treatment and the majority of subjects demonstrating clearance after only one treatment. These treatments were well tolerated and provided high patient satisfaction. Lasers Surg. Med. 49:625-631, 2017. © 2017 Wiley Periodicals, Inc.

Topics: Adolescent; Adult; Aged; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nose; Phototherapy; Prospective Studies; Single-Blind Method; Telangiectasis; Treatment Outcome; Young Adult

Predicting nasal soft tissue envelope (STE) thickness is an important component of the preoperative evaluation for rhinoplasty that presently lacks validated tools.. Assess for patient facial features and factors that can help predict nasal STE thickness.. Retrospective review and prospective assessment conducted at an academic tertiary referral center. This study included 190 adult patients and four expert raters. The patients had high-resolution maxillofacial CT scans and standardized facial photographs on file and did not have a history of nasal fracture, septal perforation, rhinoplasty, or other surgery or medical conditions altering nasal form.. Assess each face for features that could help predict nasal STE thickness: sebaceous quality of skin, visibility of nasal tip cartilages, presence of freckles, presence of telangiectasias, Fitzpatrick skin type, patient age, sex, and body mass index (BMI). Measure actual nasal STE thickness using high-resolution CT scans. Analyze which facial features and patient factors help predict nasal STE thickness.. Pearson correlations were calculated between actual nasal STE thickness and patient facial features and factors. These showed that more sebaceous skin, telangiectasias, higher Fitzpatrick skin type, male sex, and higher BMI were associated with a thicker nasal STE. Increased visibility of nasal tip cartilages, freckles, lower Fitzpatrick skin type, female sex, and lower BMI were associated with a thinner nasal STE.. There are patient facial features and factors that can help surgeons predict nasal STE thickness before rhinoplasty. An accurate prediction of nasal STE thickness can improve preoperative planning for rhinoplasty, allowing implementation of pre-, intra-, and post-operative treatments to optimize the nasal STE, which may ultimately improve patient outcomes and satisfaction.

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Delphi Technique; Female; Humans; Male; Middle Aged; Nose; Photography; Physical Examination; Prospective Studies; Retrospective Studies; Rhinoplasty; Sex Factors; Skin Physiological Phenomena; Telangiectasis; Tomography, X-Ray Computed; Young Adult

Nasal telangiectasias are superficial, small vessels in the ala nasi and nasolabial crease with a varying origin. They represent an unaesthetic condition, frustrating patients who frequently request their removal. Microsclerotherapy, electrosurgery, different types of laser therapy, needle-assisted electrocoagulation, and TRASER therapy have been described for treating this condition.. The aim of this study is to describe a novel technique that removes nasal telengectiasias using voltaic arc dermabrasion (VAD).. Voltaic arc dermabrasion treatment was used to remove nasal telangiectasia in 23 patients. The post-treatment condition was monitored by means of photographic records and the evaluation of erythema, pain score, patient and surgeon satisfaction, and skin temperature. The timing points were 1, 4, 6 days and 1 year after treatment.. Patients referred a moderate pain during the treatment that ceased at the end of the procedure. Moderate erythema and punctiform fine crusting were present in all patients that lasted until the 6th day after treatment. No other adverse effects were observed. After 1-year, the mean patient and surgeon satisfaction scores were 2.90 and 3.00 ± 0.3, respectively. A single treatment was effective in 85% of the patients and no recurrences were recorded for one year. The skin temperature increased about 18.2 ± 3.2°C during the treatment but returned to basal values in about 20 seconds in most of the patients.. Voltaic arc dermabrasion treatment is a viable, easy to use, and inexpensive tool for successful nasal telangiectasia removal, with minimal post-treatment discomfort.

Topics: Dermabrasion; Humans; Nose; Pain, Postoperative; Telangiectasis; Treatment Outcome

Rosacea is characterized by erythema on face, especially erythema and linear telangiectasia on the nose. Currently, various vascular lasers are used for treatment, and among them, are long-pulsed Nd:YAG(LPNY) and pulsed dye laser (PDL).. This study compared the efficacy of LPNY and PDL in treating rosacea-associated nasal telangiectasia.. Patients with rosacea who showed erythema and telangiectasia on the nose were included. Each patient was treated with PDL on the left side of the nasal bridge, and LPNY on the right side, three times with 4-week intervals. At the end of the treatment, two independent dermatologists evaluated overall treatment response compared with baseline.. The physician's assessment of treatment concluded that good improvement was seen in six PDL and seven LPNY patients, and excellent improvement five PDL and four LPNY patients. There was no significant difference (p = 0.62, 95%CI) between the groups. Overall improvement was similar; however, LPNY induced a greater response in thick, dilated vessels, while erythema with mild telangiectasia was more responsive to PDL.. Both LPNY and PDL are effective in treating rosacea-associated nasal telangiectasia. If LPNY is used properly to avoid side effects with careful consideration, it can also be used as a good modality.

Topics: Adult; Aged; Erythema; Facial Dermatoses; Female; Humans; Lasers, Dye; Lasers, Solid-State; Low-Level Light Therapy; Male; Middle Aged; Nose; Rosacea; Telangiectasis; Treatment Outcome

Topics: Aged, 80 and over; Carcinoma, Basal Cell; Humans; Male; Mohs Surgery; Nose; Nose Neoplasms; Telangiectasis; Treatment Outcome

Topics: Electrocoagulation; Humans; Needles; Nose; Telangiectasis; Treatment Outcome

Topics: Aged; Antineoplastic Agents; Docetaxel; Facial Dermatoses; Humans; Incidental Findings; Male; Middle Aged; Nose; Nose Diseases; Recurrence; Remission, Spontaneous; Rosacea; Taxoids; Telangiectasis

Topics: Body Piercing; Chronic Disease; Erythema; Facial Dermatoses; Female; Humans; Nose; Telangiectasis; Young Adult

Thick linear telangiectasia on the ala nasi and nasolabial crease can be resistant to treatment with the potassium-titanyl-phosphate (KTP) laser and the traditional round spot on a pulsed dye laser (PDL). We evaluated the efficacy of a 3 mm x 10 mm elliptical spot using the ultra-long pulse width on a Candela Vbeam(R) PDL for treatment of PDL- and KTP laser-resistant nasal telangiectasia. Nasal telangiectasia resistant to PDL (12 patients) and KTP laser (12 patients) in 18 patients were treated with a 3 mm x 10 mm elliptical spot on the ultra-long pulse pulsed dye laser (ULPDL) utilising long pulse width [595 nm, 40 ms, double pulse, 30:20 dynamic cooling device (DCD)]. Six patients had previously received treatment with both PDL and KTP laser prior to ULPDL (40 treatments, range1-4, mean 2.2). Complete clearance was seen in ten patients, and eight patients displayed more than 80% improvement after ULPDL treatment. Self-limiting purpura occurred with round spot PDL and erythema with KTP laser and ULPDL. Subtle linear furrows along the treatment sites were seen in three patients treated with the KTP laser. ULPDL treatment delivered using a 3 mm x 10 mm elliptical spot was non-purpuric and highly effective in the treatment of nasal telangiectasia resistant to KTP laser and PDL.

Topics: Female; Humans; Lasers, Dye; Lasers, Solid-State; Male; Middle Aged; Nose; Nose Diseases; Telangiectasis

Nasal telangiectasia is a common disfiguring condition and may cause significant psychological distress. Although lasers are effective in treating such lesions, there are many disadvantages, such as purpura, scarring, and cost.. To assess the effectiveness of a combination therapy of CO2 laser and trichloroacetic acid (TCA) for nasal telangiectasia.. Twenty patients with nasal telangiectasia were treated with CO2 laser 2 weeks after modified sclerotherapy using 80% TCA.. After one treatment session, all patients had excellent results with more than 75% vessel clearance. There were mild side effects, such as transient erythema and fine frosting. After follow-up of 1 year, there were no relapses.. We conclude that CO2 laser after modified sclerotherapy using 80% TCA appears to be a simple, effective, and inexpensive method for the treatment of nasal telangiectasia.

Topics: Combined Modality Therapy; Female; Humans; Laser Therapy; Male; Nose; Sclerosing Solutions; Sclerotherapy; Telangiectasis; Treatment Outcome; Trichloroacetic Acid

Many patients of rhytidectomy age have had previous rhinoplasty or nasal injury and have dorsal irregularities or saddle-nose deformities. SMAS tissue ordinarily discarded at rhytidectomy may be used for nasal dorsal augmentation and padding. Six patients undergoing rhytidectomy who also had prior nasal surgery or deformity were selected. Two of the patients had saddle deformities, and four had palpable and visible bony or cartilaginous irregularities. In all patients, substantial improvement was noted. In the saddle deformities, significant long-term results were achieved, with graft longevity as great as 24 months. The technique should be considered in rhytidectomy patients with concomitant nasal dorsal deformities.

Topics: Adipose Tissue; Atrophy; Esthetics; Fascia; Female; Follow-Up Studies; Graft Survival; Humans; Muscle, Skeletal; Nose; Nose Deformities, Acquired; Nose Diseases; Rhinoplasty; Rhytidoplasty; Telangiectasis; Transplantation, Autologous

The first 30 patients with telangiectasia of the nose that presented to our unit were treated with the SPTL-1 laser. The SPTL-1 laser emits pulsed light at a wavelength of 585 nm with a pulse duration of 450 microseconds. Patients with telangiectasia and diffuse spider nevi were included; patients with small spider nevi were excluded. The series included 23 females between 23 and 56 years (mean 37 years) and 7 male patients between 21 and 54 years (mean 42 years). A significant improvement was achieved in 24 patients (80%) and, on the whole, patient satisfaction was high, but more than one treatment session was required (mean of three treatment sessions per patient). At the 6-month follow-up there was some recurrence in two patients for which they required more treatment. No sign of scarring was noted in any patient, but some hypopigmentation occurred over the bridge of the nose of one patient.

Topics: Adult; Female; Humans; Laser Therapy; Male; Middle Aged; Nose; Telangiectasis

Ten patients with red nose due to telangiectasias were treated with the argon laser. Seven had telangiectasias due to rosacea, two had had rhinoplasty, and one had experienced trauma. All of the patients had a good clinical result.

Topics: Aged; Female; Humans; Laser Therapy; Male; Middle Aged; Nose; Nose Diseases; Rhinoplasty; Rosacea; Telangiectasis

Large vessels of the nose have been treated with razor blade shave technique in 5 patients. A good cosmetic result has been achieved.

Topics: Humans; Male; Methods; Nose; Nose Diseases; Telangiectasis

Nasal telangiectasias, a common condition, can be caused by chronic exposure to ultraviolet light, rosacea, topically applied corticosteroids, or rhinoplasty. Use of the argon laser for 15 to 45 minutes in a continuous mode over the entire involved area can produce considerable lightening of the nasal redness and improvement in the cosmetic appearance, as illustrated in the two cases described in this report.

Topics: Follow-Up Studies; Laser Therapy; Male; Nose; Nose Diseases; Rhinoplasty; Rosacea; Telangiectasis

A case of profuse yet distinct telangiectasia of the nose was successfully treated by light dermabrasion. Dermabrasion may be useful for treating superficial telangiectasia that are numerous and occupy a considerable area. A small test patch is recommended.

Topics: Dermabrasion; Female; Humans; Middle Aged; Nose; Telangiectasis

Prior to anticipated nasal surgery, the nasal and facial skin should be examined for any vascular lesions. The skin type should be ascertained. A history of any prior nasal surgery, particularly on the nasal dorsum, should be noted. If rosacea is a clinical possibility, a trial of 1.5 to 2.0 gm q.d. of tetracycline for 6 to 8 weeks is warranted. If, after rhinoplasty, a diffuse "redness" on the nasal dorsum results and one can exclude other diagnoses, then argon laser therapy should be considered. A 3-mm punch biopsy should be obtained to see whether superficial ectatic vessels are present, a finding that would be indicative of a good result from laser therapy.

Topics: Diagnosis, Differential; Erythema; Female; Humans; Laser Therapy; Middle Aged; Nose; Rhinoplasty; Rosacea; Skin; Telangiectasis

Topics: Arteries; Carotid Artery, External; Cryosurgery; Epistaxis; Ethmoid Sinus; Humans; Ligation; Maxillary Artery; Nose; Telangiectasis

Topics: Anemia; Arteriosclerosis; Deafness; Diagnosis, Differential; Ear; Hemangioma; Hematologic Diseases; Hematoma; Hemophilia A; Histiocytoma, Benign Fibrous; Humans; Infectious Mononucleosis; Leukemia; Nose; Pathology; Pharynx; Polycythemia; Telangiectasis

Topics: Humans; Nasal Surgical Procedures; Nose; Replantation; Telangiectasia, Hereditary Hemorrhagic; Telangiectasis

Topics: Fibroma; Humans; Medical Records; Nasal Cavity; Neoplasms; Nose; Osteoma; Paranasal Sinus Neoplasms; Paranasal Sinuses; Telangiectasis

Topics: Animals; Humans; Hydrozoa; Lupus Erythematosus, Systemic; Nose; Rosacea; Telangiectasis